Pneumologie, Table of Contents Pneumologie 2020; 74(S 01): 19DOI: 10.1055/s-0039-3403100 Posterbegehung (PO02) – Sektion Zellbiologie Neue Innovationen in der Zellbiologie Georg Thieme Verlag KG Stuttgart · New YorkFevipiprant inhibits eosinophil activation induced by multiple metabolites of prostaglandin D2 Authors Author Affiliations S Carstensen 1 Fraunhofer Institute for Toxicology and Experimental Medicine (Item) M Müller 1 Fraunhofer Institute for Toxicology and Experimental Medicine (Item) V Erpenbeck 2 Novartis Pharma AG S Kazani 3 Novartis Institutes for Biomedical Research DA Sandham 3 Novartis Institutes for Biomedical Research Recommend Article Abstract Full Text
